Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
NCT Number: NCT01263626
The aim of the study is to establish the accuracy of a new device designed specifically to record and detect cough episodes.
Cough is an important defense mechanism of the respiratory tract. The presence of chronic cough may indicate the presence of underlying diseases, including reflux. Despite the increased number of patients suffering from cough in the ENT and GI practice, to date, there has been no method/device to objectively assess the frequency of cough episodes in a given patient.
PULMOTRACK-CC, manufactured by KarmelSonix (Haifa, Israel), has recently introduced an innovative device that is able to record cough episodes and then automatically detect and count them with the help of a specific software program. This study will assess the accuracy of this novel cough monitoring and counting technology and validate potential clinical use in patients with chronic cough.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Nashville, Tennessee, 37232, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Arm 1: healthy volunteers:
Arm 2: patients:
Exclusion criteria
Time frame: 24 hours post device placement
The aim of the study is to establish the accuracy of a new device designed specifically to record and detect cough episodes.
Vanderbilt University
Other
Monitoring Cough Device - Step 1 and 2
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04703595
Ataxia, Brain Diseases
Barcelona, Spain
View Trial DetailsNCT03363698
Allergic Rhinitis, Asthma
Warsaw, Masovian Voivodeship, Poland
View Trial DetailsNCT02492126
Chronic Cough, Cough
Jacksonville, Florida, United States
View Trial DetailsNCT06999577
Cough, Deglutition Disorders
San Deigo, California, United States
View Trial Details